|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.96 USD | -0.18% |
|
-3.38% | +9.32% |
| 06-16 | Merck Signs Drug Discovery, Licensing Deal With Protillion Biosciences | MT |
| 06-16 | Moderna announces executive changes ahead of potential launches | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MERCK & CO., INC. | Specialty & Advanced Pharmaceuticals | +0.01% | -3.38% | +9.32% | +47.00% | +49.00% | 284B |  | |  |
- Stock Market
- Stocks
- MRK Stock
- Charts Merck & Co., Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition